SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001626199-21-000027
Filing Date
2021-01-06
Accepted
2021-01-06 20:03:28
Documents
1
Period of Report
2021-01-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_160998139480163.html 4  
1 FORM 4 wf-form4_160998139480163.xml 4 4530
  Complete submission text file 0001626199-21-000027.txt   6124
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ALPINE IMMUNE SCIENCES, INC. 188 EAST BLAINE STREET, SUITE 200 SEATTLE WA 98102
Business Address
PENG STANFORD L (Reporting) CIK: 0001711352 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 21512529